Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy

Mayo Clinic Proceedings

Volumn 71, Issue 12, 1996, Pages 1145-1149

  Mohamed Shakir, K M ^a   Zuhdi Jasser, M ^a   Yoshihashi, Ann K ^a   Drake III, Almond J ^a   Eisold, John F ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CALCITONIN; FOLLITROPIN; LUTEINIZING HORMONE; SEROTONIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CARCINOID SYNDROME; CASE REPORT; CATECHOLAMINE URINE LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG INDICATION; FLUSHING; GONADOTROPIN BLOOD LEVEL; HUMAN; HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; MALE; SEROTONIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0030317263     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.12.1145     Document Type: Article

References (12)

1. Godwin JD II. Carcinoid tumors: an analysis of 2,837 cases. Cancer 1975:36:560-569
2. Vinik AI, Renar IP. Neuroendocrine tumors of carcinoid variety. In: DeGroot LJ, Besser M, Burger HG, Jameson JL, Loriaux DL, Marshall JC, et al, editors. Endocrinology. Vol 3. 3rd ed. Philadelphia: Saunders, 1995: 2803-2814
3. Feldman JM. Carcinoid tumors and syndrome. Semin Oncol 1987; 14:237-246
4. Wilkin JK. Flushing reactions: consequences and mechanisms. Ann Intern Med 1981; 95:468-476
5. Aldrich LB, Moattari AR, Vinik AI. Distinguishing features of idiopathic flushing and carcinoid syndrome. Arch Intern Med 1988; 148:2614-2618
6. Feldman JM. Urinary serotonin in the diagnosis of carcinoid tumors. ClinChem 1986; 32:840-844
7. Ahlman H, Dahlstrom A, Gronstad K, Tisell LE, Oberg K, Zinner MJ, et al. The pentagastrin test in the diagnosis of the carcinoid syndrome: blockade of gastrointestinal symptoms by ketanserin. Ann Surg 1985; 201:81-86
8. Snow KJ, Boyd AE III. Management of individual tumor syndromes: medullary thyroid carcinoma and hyperparathyroidism. Endocrinol Metab Clin North Am 1994 Mar; 23:157-166
9. Roberts LJ II, Oates JA. Disorders of vasodilator hormones: the carcinoid syndrome and mastocytosis. In: Wilson JD, Foster DW, editors. Williams Textbook of Endocrinology. 8th ed. Philadelphia: Saunders, 1992: 1619-1634
10. Theodorsson-Norheim E, Norheim I, Oberg K, Brodin E, Lundberg JM, Tatemoto K, et al. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients. Biochem Biophys Res Commun 1985:131:77-83
11. Feldman JM, O'Dorisio TM. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 1986;81(Suppl6B):41-48
12. Vinik AI, Gonin J, England BG, Jackson T, McLeod MK, Cho K. Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog. J Clin Endocrinol Metab 1990; 70:1702-1709